GB0321309D0 - Crystalline therapeutic agent - Google Patents

Crystalline therapeutic agent

Info

Publication number
GB0321309D0
GB0321309D0 GB0321309A GB0321309A GB0321309D0 GB 0321309 D0 GB0321309 D0 GB 0321309D0 GB 0321309 A GB0321309 A GB 0321309A GB 0321309 A GB0321309 A GB 0321309A GB 0321309 D0 GB0321309 D0 GB 0321309D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agent
crystalline therapeutic
crystalline
agent
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0321309A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB0321309A priority Critical patent/GB0321309D0/en
Publication of GB0321309D0 publication Critical patent/GB0321309D0/en
Priority to US10/763,794 priority patent/US20040235857A1/en
Priority to PCT/IB2004/000315 priority patent/WO2004072079A1/en
Priority to TW093103036A priority patent/TW200500068A/en
Priority to ARP040100410A priority patent/AR043143A1/en
Ceased legal-status Critical Current

Links

GB0321309A 2003-02-11 2003-09-11 Crystalline therapeutic agent Ceased GB0321309D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB0321309A GB0321309D0 (en) 2003-09-11 2003-09-11 Crystalline therapeutic agent
US10/763,794 US20040235857A1 (en) 2003-02-11 2004-01-22 Crystalline therapeutic agent
PCT/IB2004/000315 WO2004072079A1 (en) 2003-02-11 2004-02-05 Hydrated and anhydrous sildenafil hemi-citrate compound
TW093103036A TW200500068A (en) 2003-02-11 2004-02-10 Crystalline therapeutic agent
ARP040100410A AR043143A1 (en) 2003-02-11 2004-02-10 CRYSTAL VARIETY OF HYDRAPHY SILDENAFIL CITRATE AND ITS USE AS A THERAPEUTIC AGENT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0321309A GB0321309D0 (en) 2003-09-11 2003-09-11 Crystalline therapeutic agent

Publications (1)

Publication Number Publication Date
GB0321309D0 true GB0321309D0 (en) 2003-10-15

Family

ID=29226914

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0321309A Ceased GB0321309D0 (en) 2003-02-11 2003-09-11 Crystalline therapeutic agent

Country Status (1)

Country Link
GB (1) GB0321309D0 (en)

Similar Documents

Publication Publication Date Title
GB0303910D0 (en) Therapeutic agents
GB0308318D0 (en) Therapeutic agents
GB0314079D0 (en) Therapeutic agents
GB0314057D0 (en) Therapeutic agents
GB0313250D0 (en) Therapeutic agents
GB0310401D0 (en) Therapeutic agent
GB0323378D0 (en) Therapeutic agent
GB0314049D0 (en) Therapeutic agents
GB0323258D0 (en) Therapeutic compounds
GB0311859D0 (en) Therapeutic agents
GB0311201D0 (en) Therapeutic agents
GB0301350D0 (en) Therapeutic agents
GB0304524D0 (en) Therapeutic agents
GB0314075D0 (en) Therapeutic agents
GB0314078D0 (en) Therapeutic agents
GB0307333D0 (en) Therapeutic agent
GB0303097D0 (en) Crystalline therapeutic agent
GB0321309D0 (en) Crystalline therapeutic agent
GB0303084D0 (en) Chrystalline therapeutic agent
GB0307335D0 (en) Therapeutic agent
GB0310402D0 (en) Therapeutic agent
EP1627632A4 (en) Therapeutic agent
GB0327426D0 (en) Therapeutic compounds
GB0327425D0 (en) Therapeutic compounds
GB0315140D0 (en) Therapeutic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)